Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.

[1]  Yoshiyuki Suzuki,et al.  FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value. , 2006, Gynecologic oncology.

[2]  S. Leung,et al.  Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma. , 2005, Clinical chemistry.

[3]  A. King,et al.  A randomized phase II study of concurrent cisplatin-radiotherapy (RT) with or without neoadjuvant chemotherapy using docetaxel and cisplatin in advanced nasopharyngeal carcinoma (NPC) , 2005 .

[4]  T. Chen,et al.  Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. , 2005, Journal of Nuclear Medicine.

[5]  Joon-Kyoo Lee,et al.  Prognostic Value of Tumor Volume in Nasopharyngeal Carcinoma , 2005, Yonsei medical journal.

[6]  J. Eary,et al.  Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  T. Yen,et al.  The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  P. Vernon,et al.  Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  Ching-Han Hsu,et al.  Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Thomas Beyer,et al.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Leung,et al.  Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma. , 2004, Clinical chemistry.

[12]  Jean-François Daisne,et al.  Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.

[13]  T. Mok,et al.  Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Y. Yonekura,et al.  Expression of GLUT‐1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F‐18]‐fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary , 2004, International journal of cancer.

[15]  Sven N. Reske,et al.  Biological characterisation of breast cancer by means of PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  Rick Chappell,et al.  Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. , 2004, International journal of radiation oncology, biology, physics.

[17]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[18]  D. Haller,et al.  Of Looking Back and Looking Forward , 2004 .

[19]  S. Leung,et al.  Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated type , 2003, Cancer.

[20]  Richard L Wahl,et al.  Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements. , 2003, Seminars in nuclear medicine.

[21]  S. Leung,et al.  Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. , 2003, Cancer research.

[22]  N. Raab-Traub.  Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.

[23]  S. Leung,et al.  Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. , 2002, Journal of the National Cancer Institute.

[24]  Mark Muzi,et al.  In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  S. Gambhir.  Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[26]  P. Johnson,et al.  Plasma nucleic acids in the diagnosis and management of malignant disease. , 2002, Clinical chemistry.

[27]  Y. Shiau,et al.  Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy , 2002, Journal of Cancer Research and Clinical Oncology.

[28]  Paul J. van Diest,et al.  Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography , 2002 .

[29]  W. Mann,et al.  [Fluorine-18]Fluorodeoxyglucose Positron Emission Tomography, DNA Ploidy and Growth Fraction in Squamous-Cell Carcinomas of the Head and Neck , 2001, ORL.

[30]  F. O. Fackelmayer,et al.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.

[31]  S. Leung,et al.  Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. , 2000, Cancer research.

[32]  D. Wood,et al.  Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  A. King,et al.  Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease , 2000, Head & neck.

[34]  S. Nagata.  Apoptotic DNA fragmentation. , 2000, Experimental cell research.

[35]  S. Leung,et al.  Plasma Cell‐free Epstein‐Barr Virus DNA Quantitation in Patients with Nasopharyngeal Carcinoma: Correlation with Clinical Staging , 2000, Annals of the New York Academy of Sciences.

[36]  A. Folpe,et al.  (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  A. King,et al.  MRI of local disease in nasopharyngeal carcinoma: tumour extent vs tumour stage. , 1999, The British journal of radiology.

[38]  S. Leung,et al.  Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. , 1999, Cancer research.

[39]  T. Yen,et al.  Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M van Herk,et al.  The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. , 1997, International journal of radiation oncology, biology, physics.

[41]  D. Chua,et al.  Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. , 1997, International journal of radiation oncology, biology, physics.

[42]  Kathryn Flynn,et al.  Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. , 1995, The New England journal of medicine.